Tag: Heliostar

Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations

Rhythm by 0 comments

The HELIOSTAR™ Balloon Ablation Catheter’s unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solution1 IRVINE, Calif., Oct. 13, 2022 /PRNewswire/ — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, […]

Continue Reading →

Texas Cardiac Arrhythmia Institute of St. David’s Medical Center is the first in the United States to treat patient under study for evaluation of the ablation catheter-balloon for the treatment of atrial fibrillation

Rhythm by 0 comments

AUSTIN, Texas , February 13, 2019 / PRNewswire / – The Texas Cardiac Arrhythmia Institute (TCAI) of St. David’s Medical Center recently conducted the first procedure in the United States using the new multi-electrode radiofrequency (RF) ablation balloon catheter, HELIOSTAR as […]

Continue Reading →

First Patient Treated In Biosense Webster U.S. IDE Study Evaluating Next Generation Balloon Ablation Catheter For Atrial Fibrillation

Rhythm by 0 comments

IRVINE, Calif., Nov. 29, 2018 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its STELLAR** U.S. Investigational […]

Continue Reading →